Silent susceptibility-weighted angiography to detect hemorrhagic lesions in the brain. A clinical and phantom study

To compare the effectiveness of silent susceptibility-weighted angiography (sSWAN), a new imaging technique with lower acoustic noise, with conventional susceptibility-weighted angiography (cSWAN) in the detection of intracranial hemorrhagic lesions. We measured the acoustic and background noise during sSWAN and cSWAN imaging and calculated the contrast-to-noise ratio (CNR) of the phantom consisting of eight chambers with different concentrations of superparamagnetic iron oxide. In the clinical study, we calculated the CNRs of hemorrhagic lesions in 15 patients and evaluated the images for conspicuity and artifact on each sequence and scored them on a 4-point scale. We also evaluated whether hypointense areas observed on sSWAN or cSWAN increased in size from those on T2*-weighted imaging (T2*-WI). Acoustic noise for sSWAN (57.9 ± 0.32 dB [background noise 51.3 dB]) was significantly less than that for cSWAN (89.0 ± 0.22 dB [background noise 50.9 dB]). The CNRs of phantoms for sSWAN were slightly but not significantly lower than those for cSWAN (P = 0.18). The CNRs of hemorrhagic lesions did not show significant differences between sSWAN and cSWAN (P = 0.17). There were no significant differences between sSWAN and cSWAN with respect to the scores for conspicuity, artifact, and change in size of hypointense areas from T2*-WI. sSWAN is equivalent to cSWAN with respect to the image quality for the detection of hemorrhagic lesions but has lower acoustic noise.